RMMS consists of nearly 40 attorneys focused exclusively in the field of pharmaceutical patent and regulatory counseling, and litigation under Hatch-Waxman, the Medicare Modernization Act (MMA), the Biologics Price Competition and Innovation Act (BPCIA).
Nearly 30 of our attorneys have technical degrees or backgrounds in a variety of areas and disciplines, including chemistry, biochemistry, biology, molecular biology, microbiology, genetics, bacteriology, bioengineering, biomedical engineering, chemical engineering and pharmacy, and the majority of our attorneys are registered with the USPTO. RMMS also employs full-time Ph.D. technical advisors specializing in chemistry, biological sciences, and pharmaceutics/pharmacy.
Our experience is unparalleled in the industry. Since the firm’s inception in 2004, RMMS has handled over 300 Hatch-Waxman/BPCIA and related pharmaceutical litigation matters (including declaratory judgment, patent infringement, Administrative Procedure Act (APA), and commercial dispute matters) involving at least 160 different drug products for over 25 pharmaceutical clients. In addition to our substantial litigation experience, our attorneys also have extensive regulatory and legislative experience. Please visit our Profiles to learn more about the RMMS team.
We appreciate your taking the time to learn more about RMMS. If you have any questions or concerns, or would like to make an appointment to speak with one of our attorneys, please call us at (312) 527-2157 or fill out the form on the Contact page, and someone from the firm will be in touch with you shortly. We look forward to hearing from you.